BCLI
Brainstorm Cell Therapeutics, Inc.
Halal Rating :
Last Price
$1.88
Last updated:
Market Cap
-
7D Change
-6.93%
1 Year Change
541.42%
Company Overview
Industries
Exchange
Next Earnings Date
Brainstorm Cell Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases. Their lead product candidate, NurOwn®, is designed to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases using autologous mesenchymal stem cells that have been engineered to secrete neurotrophic factors.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Brainstorm Cell Therapeutics, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.